InvestorsHub Logo

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
Jumboo Free
04/18/16 2:07 PM
profile icon
PStockPickz Free
04/18/16 1:21 PM
profile icon
venturecapp Free
04/18/16 10:19 AM
profile icon
blue finch Free
04/18/16 8:50 AM
profile icon
blue finch Free
04/18/16 8:25 AM
profile icon
blue finch Free
04/18/16 7:51 AM
profile icon
gregque Free
04/18/16 7:26 AM
profile icon
blue finch Free
04/18/16 7:23 AM
profile icon
gregque Free
04/18/16 7:22 AM
profile icon
gregque Free
04/18/16 7:19 AM
profile icon
blue finch Free
04/18/16 7:16 AM
profile icon
HoaxDevil Free
04/18/16 7:14 AM
profile icon
chemist72 Free
04/17/16 11:03 PM
profile icon
corncakes0 Free
04/17/16 11:37 AM
profile icon
chemist72 Free
04/17/16 10:49 AM
profile icon
blue finch Free
04/16/16 8:18 AM
profile icon
blue finch Free
04/16/16 8:18 AM
profile icon
gregque Free
04/15/16 6:32 PM
profile icon
gregque Free
04/15/16 6:25 PM
profile icon
gregque Free
04/15/16 6:24 PM
profile icon
gregque Free
04/15/16 6:23 PM
profile icon
blue finch Free
04/15/16 6:20 PM
profile icon
gregque Free
04/15/16 6:18 PM
profile icon
gregque Free
04/15/16 6:16 PM
profile icon
gregque Free
04/15/16 6:01 PM
profile icon
wplong89 Free
04/15/16 3:14 PM
profile icon
gregque Free
04/15/16 3:11 PM
profile icon
gregque Free
04/15/16 2:48 PM
profile icon
gregque Free
04/15/16 10:17 AM
profile icon
jojo1982 Free
04/15/16 10:09 AM
profile icon
jojo1982 Free
04/15/16 10:08 AM
profile icon
gregque Free
04/15/16 9:53 AM
profile icon
gregque Free
04/15/16 9:24 AM
profile icon
Ruffieruff Free
04/15/16 9:19 AM
profile icon
gregque Free
04/15/16 9:16 AM
profile icon
blue finch Free
04/15/16 7:20 AM
profile icon
gregque Free
04/15/16 6:57 AM
profile icon
wplong89 Free
04/14/16 8:35 PM

Chiasma, Inc. (CHMA) RSS Feed

Followers
13
Posters
38
Posts (Today)
0
Posts (Total)
124
Created
01/26/16
Type
Free
Moderators
We are a late-stage biopharmaceutical company focused on improving the lives of patients suffering from orphan diseases by developing and commercializing novel oral forms of therapies that are available today only by injection. Using our proprietary Transient Permeability Enhancer, or TPE, technology platform, we seek to develop oral therapies that eliminate the significant limitations and burdens generally associated with existing injectable therapies. We have completed a multinational Phase 3 clinical trial of our most advanced TPE platform-based product candidate, oral octreotide, for the treatment of acromegaly, a condition that results in the body's production of excess growth hormone. Octreotide is an analog of somatostatin, a natural inhibitor of growth hormone secretion. We believe that our lead product candidate, if approved by regulatory authorities, will be the first somatostatin analog available for oral administration. Read more: http://www.nasdaq.com/symbol/chma#ixzz3yOrPl9Wm
Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
CHMA Latest News
  • No Recent News Available for this company!
New Post